Skip to content

Value indication

Roughly what is an SME worth on what it filed? A range from its adjusted equity and its earnings, with your own assumptions, recalculated as you go.

Value indication

DOX NV

BE 0404.016.678
NACE 46.492, Wholesale trade
latest balance sheet 30-09-2025indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€432,061 to €517,492

Midpoint €467,657 · 50% capitalised earnings, 50% adjusted equity

Adjusted equity €436,965
Capitalised earnings €427,157 to €598,020
Indication €432,061 to €517,492

Your assumptions

Capitalised earnings
%

The return a buyer expects on the money put in. Higher for more risk. The range also computes with 2 points more and less.

Adjust the equity
Blend
50%
Optional: your own multiple

Checked holds no market prices, so it suggests no multiple. If you have one from a transaction or a study, the tool applies it to the filed EBITDA less the net financial debt.

Adjusted equity

balance sheet 30-09-2025
Equity (10/15)
€645,131
Intangible fixed assets (21)
-€208,166
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€436,965

Capitalised earnings

net result for the year (9904)
2025
€78,338
2024
€9,500
2023
€91,568
2022
-€8,888
2021
-€60,946
Average result
€59,802
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€427,157 / €498,350 / €598,020

What this indication leaves out

  • Market prices and comparable transactions: Checked does not hold them.
  • Anything after the latest accounts, and items off the balance sheet (guarantees, leases, disputes).
  • The real value of buildings, stock and receivables: enter your own revaluation or adjustment.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale.

For a valuation to decide on: a company auditor or a certified accountant.

Source: filed annual accounts (NBB), latest balance sheet at 30 September 2025. Prepared on 27 September 2026 via checked.be. Indication, not a valuation or advice.